MBL Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Sell |
660
-26
| -4% | -$10.5K | 0.03% | 204 |
|
|
2025
Q1 | $341K | Buy |
686
+28
| +4% | +$13.9K | 0.03% | 166 |
|
|
2024
Q4 | $342K | Sell |
658
-368
| -36% | -$191K | 0.03% | 159 |
|
|
2024
Q3 | $635K | Buy |
1,026
+417
| +68% | +$258K | 0.07% | 121 |
|
|
2024
Q2 | $337K | Sell |
609
-345
| -36% | -$191K | 0.04% | 148 |
|
|
2024
Q1 | $554K | Buy |
954
+322
| +51% | +$187K | 0.06% | 122 |
|
|
2023
Q4 | $335K | Sell |
632
-5
| -0.8% | -$2.65K | 0.04% | 132 |
|
|
2023
Q3 | $322K | Buy |
637
+104
| +20% | +$52.6K | 0.05% | 135 |
|
|
2023
Q2 | $278K | Sell |
533
-524
| -50% | -$273K | 0.04% | 139 |
|
|
2023
Q1 | $609K | Buy |
1,057
+541
| +105% | +$312K | 0.1% | 89 |
|
|
2022
Q4 | $284K | Sell |
516
-29
| -5% | -$16K | 0.05% | 130 |
|
|
2022
Q3 | $276K | Buy |
545
+141
| +35% | +$71.4K | 0.06% | 127 |
|
|
2022
Q2 | $219K | Sell |
404
-380
| -48% | -$206K | 0.05% | 131 |
|
|
2022
Q1 | $463K | Buy |
+784
| New | +$463K | 0.11% | 102 |
|
|
2021
Q1 | $317K | Buy |
696
+74
| +12% | +$33.7K | 0.11% | 111 |
|
|
2020
Q4 | $290K | Buy |
+622
| New | +$290K | 0.11% | 102 |
|